In this first-ever proof-of-concept study for the therapeutic potential of human iPSC-derived cells in a pulmonary disease, Christine Happle and colleagues use Chipcytometry to analyse the successful transplantation of these cells in a humanized mouse model of hereditary pulmonary alveolar proteinosis (herPAP).
